Wednesday, September 13, 2023 8:48:51 AM
Source: GlobeNewswire Inc.
Castellum, Inc. (NYSE-American: CTM) (“Castellum”) announces that its Specialty Systems, Inc. subsidiary has been awarded a $3 million, 14-month U.S. Navy contract.
With this contract, Castellum furthers the commitment to its U.S. Navy mission.
“This is an important contract award as it will permit us to support our U.S. Navy mission customer by maximizing the readiness of the forces as they address a multitude of global threats,” said Mark Fuller, President and Chief Executive Officer of Castellum. “We are constantly looking for opportunities to leverage our expertise and past performance by creating new ways to support the national security imperatives of all the Castellum mission customers.”
About Castellum, Inc.
Castellum, Inc. (NYSE-American: CTM)?is a defense-oriented technology company, which is executing strategic acquisitions in the cyber security, information technology and software, information warfare, and electronic warfare and engineering services space - http://castellumus.com/
Forward-Looking Statements:?
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements represent the Company’s expectations or beliefs concerning future events and can generally be identified by the use of statements that include words such as “estimate,” “project,” “believe,” “anticipate,” “shooting to,” “intend,” “plan,” “foresee,” “likely,” “will,” “would,” “appears,” “goal,” “target” or similar words or phrases. Forward-looking statements include, but are not limited to, statements regarding the Company’s expectations for revenue growth and new customer opportunities, improvements to cost structure, and profitability. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company’s control, that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements, including, among others: the Company’s ability to compete against new and existing competitors; its ability to effectively integrate and grow its acquired companies; its ability to identify additional acquisition targets and close additional acquisitions; the impact on the Company’s revenue due to a delay in the U.S. Congress approving a federal budget; and the Company’s ability to maintain the listing of its common stock on the NYSE American LLC. For a more detailed description of these and other risk factors, please refer to the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission (“SEC”) which can be viewed at www.sec.gov. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. The Company expressly disclaims any intent or obligation to update any of the forward-looking statements made in this release or in any of its SEC filings except as may be otherwise stated by the Company.
Contact:
Mark Fuller
President and Chief Executive Officer
Contact: info@castellumus.com
Phone: (301) 961-4895
Primary Logo
Recent CTM News
- Castellum, Inc. Announces New Strategic Alliance • GlobeNewswire Inc. • 04/18/2024 10:45:00 AM
- Castellum, Inc. Announces 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 10:45:00 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/27/2024 10:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:33:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:02:34 PM
- Castellum, Inc. Announces Closing of $4 Million Revolver with Live Oak Bank • GlobeNewswire Inc. • 02/23/2024 11:45:00 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/16/2024 09:43:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 11:31:23 AM
- Castellum Announces Closing of $2.7 Million Registered Direct Offering • GlobeNewswire Inc. • 01/29/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:32:36 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/29/2024 11:31:16 AM
- Castellum Announces Pricing of $2.7 Million Registered Direct Offering • GlobeNewswire Inc. • 01/25/2024 01:55:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:24 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/01/2023 09:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:08:32 PM
- Castellum, Inc. Announces Execution of Debt Term Sheet • GlobeNewswire Inc. • 11/27/2023 11:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:06:08 PM
- Castellum, Inc. Announces Third Quarter Financial Results • GlobeNewswire Inc. • 11/14/2023 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:05:41 PM
- Castellum, Inc. Announces Bob Eisiminger, as Senior Advisor • GlobeNewswire Inc. • 10/31/2023 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:04:03 PM
- Castellum, Inc. Announces 2024 Budget Targets and Strategic Initiatives • GlobeNewswire Inc. • 10/20/2023 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:15:24 PM
- Castellum Announces the Award of a $3 million Contract to its Specialty Systems, Inc. Subsidiary • GlobeNewswire Inc. • 08/29/2023 10:45:00 AM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM